RCT Comparing 19Ga vs 22Ga EBUS-TBNA Needles in Carcinoma.
Phase 3
- Conditions
- Lung Neoplasm
- Interventions
- Device: EBUS-TBNA needle
- First Posted Date
- 2016-09-20
- Last Posted Date
- 2016-09-20
- Lead Sponsor
- KU Leuven
- Target Recruit Count
- 78
- Registration Number
- NCT02906280
- Locations
- π§πͺ
University Hospitals KU Leuven, Leuven, Belgium
Protocol of a Pilot Study to Optimize Care for Heart Failure Patients in Primary Care
Not Applicable
Completed
- Conditions
- Heart Failure
- First Posted Date
- 2016-09-19
- Last Posted Date
- 2018-07-19
- Lead Sponsor
- KU Leuven
- Target Recruit Count
- 538
- Registration Number
- NCT02905786
- Locations
- π§πͺ
Departement of Public Health and Primary Care, Leuven, Belgium
Exercise in Peripheral Artery Disease
Not Applicable
- Conditions
- Peripheral Artery DiseaseIntermittent Claudication
- Interventions
- Other: Exercise sessionOther: No intervention (Observational study)Other: Control session
- First Posted Date
- 2016-08-25
- Last Posted Date
- 2016-08-25
- Lead Sponsor
- KU Leuven
- Target Recruit Count
- 160
- Registration Number
- NCT02878954
Walking Training in Peripheral Artery Disease (GrEnADa Sub-study)
Not Applicable
Withdrawn
- Conditions
- Intermittent ClaudicationPeripheral Artery Disease
- Interventions
- Other: Stretching exercise groupOther: Walking training group
- First Posted Date
- 2016-08-25
- Last Posted Date
- 2019-06-24
- Lead Sponsor
- KU Leuven
- Registration Number
- NCT02879019
Investigating Patient Satisfaction With Oral Anti-cancer Treatment in Patients With Hormone-receptor Positive, HER2-receptor Negative, Advanced Breast Cancer
- Conditions
- ER Positive, HER2 Negative Breast Cancer Neoplasms
- First Posted Date
- 2016-08-23
- Last Posted Date
- 2016-08-23
- Lead Sponsor
- KU Leuven
- Target Recruit Count
- 100
- Registration Number
- NCT02875951
- Locations
- π§πͺ
Katholieke Universiteit Leuven - Clinical Pharmacology and Pharmacotherapeutics, Leuven, Brabant, Belgium
Collaborative Network to Take Responsibility for Oral Anticancer Therapy
Not Applicable
- Conditions
- Lung CancerMelanomaColorectal CancerALLProstate CancerBreast Cancer
- Interventions
- Other: Implementation of a care pathway
- First Posted Date
- 2016-08-10
- Last Posted Date
- 2019-04-16
- Lead Sponsor
- KU Leuven
- Target Recruit Count
- 228
- Registration Number
- NCT02861209
- Locations
- π§πͺ
Imelda Bonheiden, Bonheiden, Vlaams-Brabant, Belgium
π§πͺAZ Groeninge Kortrijk, Kortrijk, West-Vlaanderen, Belgium
π§πͺAZ Turnhout, Turnhout, Antwerpen, Belgium
Prospective Validation and Comparison of Different Ultrasound Methods for Discrimination Between Benign and Malignant Ovarian/Tubal Masses Prior to Surgery
- Conditions
- Patients With Adnexal Mass Prior to Surgery
- First Posted Date
- 2016-07-28
- Last Posted Date
- 2020-04-14
- Lead Sponsor
- KU Leuven
- Target Recruit Count
- 1700
- Registration Number
- NCT02847832
- Locations
- π§πͺ
University Hospitals Leuven, Leuven, Belgium
Retrospective Analysis of Hospital Medical Records on Medication and Supplement Use in Pregnant Women
Completed
- Conditions
- Medication and Supplement Use During Pregnancy
- First Posted Date
- 2016-07-22
- Last Posted Date
- 2017-08-22
- Lead Sponsor
- KU Leuven
- Target Recruit Count
- 1200
- Registration Number
- NCT02842216
Value of MRI in the Characterization of Ovarian Masses Unable to Classify With Ultrasound Using the International Ovarian Tumor Analysis (IOTA) Simple Rules
Not Applicable
- Conditions
- Patients With a Sonographically Unclassifiable Adnexal Mass Using the IOTA Simple Rules
- Interventions
- Other: Diffusion/Perfusion-weighted Magnetic Resonance Imaging
- First Posted Date
- 2016-07-19
- Last Posted Date
- 2020-04-14
- Lead Sponsor
- KU Leuven
- Target Recruit Count
- 250
- Registration Number
- NCT02836275
- Locations
- π§πͺ
University Hospitals Leuven, Leuven, Belgium
The Impact of Modified Wheat Bran on Carbohydrate Fermentation in the Colon in Healthy and Obese Subjects
Phase 1
Completed
- Conditions
- HealthyObese
- Interventions
- Dietary Supplement: Wheat branDietary Supplement: Placebo
- First Posted Date
- 2016-06-13
- Last Posted Date
- 2021-02-26
- Lead Sponsor
- KU Leuven
- Target Recruit Count
- 50
- Registration Number
- NCT02796989
- Locations
- π§πͺ
KU Leuven, Leuven, Vlaams-Brabant, Belgium
Β© Copyright 2025. All Rights Reserved by MedPath